Based on the stock exchange rules „On Listing and Trading of Financial Instruments on the Markets Regulated by the Exchange” 14.8.6 point, JSC „Rīgas farmaceitiskā fabrika” explains that the non-audited 2012th annual report net profit amounted to 16 816 LVL, but after the audited annual report accounts 24 017 LVL, this is explained mainly by the fact that the certified auditor requirements were adjusted deferred corporate income tax liability calculation.